name: BASC-3 externalizing problems composite score


name: BASC-3 externalizing problems percentile


name: BASC-3 externalizing problems confidence index


name: BASC-3 internalizing problems composite score


name: BASC-3 internalizing problems percentile


name: BASC-3 internalizing problems confidence index


name: BASC-3 behavior symptoms index percentile


name: BASC-3 behavior symptoms index confidence index


name: BASC-3: self report of personality composite score


name: BASC-3 self report: personal adjustment T-score


name: BASC-3 self report: personal adjustment percentile


name: BASC-3 self report: emotional symptoms T-score


name: BASC-3 self report: emotional symptoms percentile


name: BASC-3: self report of clinical and adaptive scales


name: BASC-3 self report: attitude to school T-score


name: BASC-3 self report: attitude to school percentile


name: BASC-3 self report: attitude to teachers


name: BASC-3 self report: attitude to teachers T-score


name: BASC-3 self report: attitude to teachers percentile


name: BASC-3 self report: sensation seeking T-score


name: BASC-3 self report: sensation seeking percentile


name: BASC-3 self report: atypicality percentile


name: BASC-3 self report: locus of control T-score


name: BASC-3 self report: locus of control percentile


name: BASC-3 self report: social stress T-score


name: BASC-3 self report: social stress percentile


name: BASC-3 self report: depression percentile


name: BASC-3 self report: sense of inadequacy T-score


name: BASC-3 self report: sense of inadequacy percentile


name: BASC-3 self report: somatization T-score


name: BASC-3 self report: somatization percentile


name: BASC-3 self report: attention problems T-score


name: BASC-3 self report: attention problems percentile


name: BASC-3 self report: hyperactivity T-score


name: BASC-3 self report: hyperactivity percentile


name: BASC-3 self report: interpersonal relations


name: BASC-3 self report: interpersonal relations T-score


name: BASC-3 self report: interpersonal relations percentile


name: BASC-3 self report: relations with parents


name: BASC-3 self report: relations with parents T-score


name: BASC-3 self report: relations with parents percentile


name: BASC-3 self report: school maladjustment score


name: BASC-3 self report: school maladjustment T-score


name: BASC-3 self report: school maladjustment percentile


name: BASC-3 self report: self esteem percentile


name: BASC-3 self report: self reliance T-score


name: BASC-3 self report: self reliance percentile


name: BASC-3: self report of personality content scale


name: NAA with probe detection for Trichomonas vaginalis DNA


name: NAA with probe detection for Trichomonas vaginalis DNA in vaginal fluid


name: NAA with probe detection for bacterial vaginosis DNA and score panel


name: NAA with probe detection for bacterial vaginosis DNA and score panel in vaginal fluid


name: urobilinogen presence in urine by test strip


name: viral Epstein-Barr IgM early antibody in serum


name: BRIEF-2 self-monitor scale confidence index


name: BRIEF-2 behavior regulation index (BRI) raw score


name: BRIEF-2 behavior regulation index (BRI) T-score


name: BRIEF-2 behavior regulation index (BRI) percentile


name: BRIEF-2 behavior regulation index (BRI) confidence index


name: BRIEF-2 behavior regulation index (BRI) shift


name: BRIEF-2 behavior regulation index (BRI) shift raw score


name: BRIEF-2 behavior regulation index (BRI) shift T-score


name: BRIEF-2 behavior regulation index (BRI) shift percentile


name: BRIEF-2 behavior regulation index (BRI) shift confidence index


name: BRIEF-2 behavior regulation index (BRI) emotional control


name: BRIEF-2 behavior regulation index (BRI) emotional control raw score


name: BRIEF-2 behavior regulation index (BRI) emotional control T-score


name: BRIEF-2 behavior regulation index (BRI) emotional control percentile


name: BRIEF-2 behavior regulation index (BRI) emotional control confidence index


name: BRIEF-2 emotion regulation index (ERI) raw score


name: BRIEF-2 emotion regulation index (ERI) T-score


name: BRIEF-2 emotion regulation index (ERI) percentile


name: BRIEF-2 emotion regulation index (ERI) confidence index


name: BRIEF-2 emotion regulation index (ERI) initiate


name: BRIEF-2 emotion regulation index (ERI) initiate raw score


name: BRIEF-2 emotion regulation index (ERI) initiate T-score


name: BRIEF-2 emotion regulation index (ERI) initiate percentile


name: BRIEF-2 emotion regulation index (ERI) initiate confidence index


name: BRIEF-2 emotion regulation index (ERI) working memory


name: BRIEF-2 emotion regulation index (ERI) working memory raw score


name: BRIEF-2 emotion regulation index (ERI) working memory T-score


name: BRIEF-2 emotion regulation index (ERI) working memory percentile


name: BRIEF-2 emotion regulation index (ERI) working memory confidence index


name: BRIEF-2 emotion regulation index (ERI) plan/organize


name: BRIEF-2 emotion regulation index (ERI) task-monitor


name: BRIEF-2 emotion regulation index (ERI) plan/organize raw score


name: BRIEF-2 emotion regulation index (ERI) plan/organize T-score


name: BRIEF-2 emotion regulation index (ERI) plan/organize percentile


name: BRIEF-2 emotion regulation index (ERI) plan/organize confidence index


name: BRIEF-2 emotion regulation index (ERI) task-monitor raw score


name: BRIEF-2 emotion regulation index (ERI) task-monitor T-score


name: BRIEF-2 emotion regulation index (ERI) task-monitor percentile


name: BRIEF-2 emotion regulation index (ERI) task-monitor confidence index


name: BRIEF-2 cognitive regulation index (CRI)


name: BRIEF-2 cognitive regulation index (CRI) raw score


name: BRIEF-2 cognitive regulation index (CRI) T-score


name: BRIEF-2 cognitive regulation index (CRI) percentile


name: BRIEF-2 cognitive regulation index (CRI) confidence index


name: BRIEF-2 global executive composite (GEC)


name: BRIEF-2 global executive composite (GEC) raw score


name: BRIEF-2 global executive composite (GEC) T-score


name: BRIEF-2 global executive composite (GEC) percentile


name: BRIEF-2 global executive composite (GEC) confidence index


name: BASC-3 developmental social disorders content scale


name: BASC-3 developmental social disorders T-score


name: BASC-3 developmental social disorders percentile


name: BASC-3 developmental social disorders confidence index


name: BASC-3 emotional self-control content scale


name: BASC-3 emotional self-control percentile


name: BASC-3 emotional self-control confidence index


name: BASC-3 executive functioning content scale


name: BASC-3 executive functioning confidence index


name: BASC-3 negative emotionality content scale


name: BASC-3 negative emotionality confidence index


name: BASC-3 overall executive functioning index


name: BASC-3 ADHD probability index percentile


name: BASC-3 ADHD probability index - confidence index


name: BASC-3 autism probability index percentile


name: BASC-3 autism probability index - confidence index


name: BASC-3 clinical probability index T-score


name: BASC-3 clinical probability index percentile


name: BASC-3 clinical probability index confidence index


name: BASC-3 EBD probability index - confidence index


name: BASC-3 functional impairment index T-score


name: BASC-3 functional impairment index percentile


name: BASC-3 functional impairment index - confidence index


name: BASC-3 self report: inattention/hyperactivity


name: BASC-3 self report: inattention/hyperactivity T-score


name: BASC-3 self report: inattention/hyperactivity percentile


name: BASC-3 self report: internalizing problems


name: BASC-3 self report: internalizing problems T-score


name: BASC-3 self report: internalizing problems percentile


name: BASC-3 self report: school problems T-score


name: BASC-3 self report: school problems percentile


name: BASC-3 self report: composite score total


name: BASC-3 self report: composite score total T-score


name: BASC-3 self report: composite score total percentile


name: BASC-3 self report: alcohol abuse T-score


name: BASC-3 self report: alcohol abuse percentile


name: BASC-3 self report: anger control T-score


name: BASC-3 self report: anger control percentile


name: BASC-3 self report: anger control confidence index


name: BASC-3 self report: ego strength T-score


name: BASC-3 self report of ego strength percentile


name: BASC-3 self report: ego strength confidence index


name: BASC-3 self report: mania confidence index


name: BASC-3 self report: test anxiety T-score


name: BASC-3 self report: test anxiety percentile


name: BASC-3 self report: test anxiety confidence index


name: biopsy stomach tissue showed increased eosinophils


name: imaging studies nonspecific abnormal findings joint erosion


name: imaging studies joint erosion number of joints affected


name: Ultrasonic guidance for needle placement


name: lower extremity functional scale questionnaire


name: peak expiratory flow post-bronchodilation


name: blood pH adjusted to patient's actual temperature


name: RBC morphology - dual population of erythrocytes


name: RBC morphology - hyperchromic erythrocytes


name: RBC morphology - irregularly contracted cells


name: RMC morphology, normocytic red blood cells


name: platelet morphology - agranular platelets


name: calcium hydrogen phosphate dihydrate crystals in urine


name: nasopharyngeal culture for Haemophilus influenzae


name: nasopharyngeal culture for Moraxella catarrhalis


name: nasopharyngeal culture for Streptococcus pneumoniae


name: oropharynx culture for Moraxella catarrhalis


name: arterial PaCO2 adjusted to patient's actual temperature


name: arterial PaO2 adjusted to patient's actual temperature


name: arterial cord blood pH adjusted to patient's actual temperature


name: cardioverter-defibrillator sustained ventricular flutters


name: cardioverter-defibrillator sustained ventricular flutters successfully cardioverted


name: stress test ECG at rest: ventricular flutter


name: cath complications arrhythmias ventricular flutter


name: nonvascular ultrasound of complete joint of extremity


name: limited nonvascular ultrasound of joint or focal evaluation of other structure of extremity


name: SLCO1B1 variant of uncertain significance


name: genome sequence analysis panel for hereditary peripheral neuropathies


name: MAAA for oncology with microarray expression profiling of 70 content and 465 housekeeping genes


name: multianalyte assay with algorithmic analysis for oncology with mRNA expression profiling by real-time RT-PCR of 46 genes


name: multianalyte assays with algorithmic analyses for oncology with real-time PCR promoter methylation profiling of 3 genes


name: recombinant or purified allergen component specific IgE


name: Attention Deficit Disorders Evaluation Scale


name: joint swelling affecting number of joints


name: joint tenderness affecting number of joints


name: nodule on right external auditory canal wall


name: nodule on left external auditory canal wall


name: nodule on both external auditory canal walls


name: nodules on proximal aspect of right middle finger


name: nodules on distal aspect of right middle finger


name: nodules on proximal aspect of right thumb


name: nodules on lateral aspect of right thumb


name: nodules on periungual aspect of right thumb


name: nodules on proximal aspect of right index finger


name: nodules on distal aspect of right index finger


name: nodules on dorsal aspect of right index finger


name: nodules on palmar aspect of right index finger


name: nodules on medial aspect of right index finger


name: nodules on lateral aspect of right index finger


name: nodules on periungual aspect of right index finger


name: scales on multiple fingers of right hand


name: nodules on proximal aspect of right forearm


name: nodules on distal aspect of right forearm


name: nodules on volar aspect of right forearm


name: nodules on dorsal aspect of right forearm


name: nodules on medial aspect of right forearm


name: nodules on lateral aspect of right forearm


name: nodules on proximal aspect of left forearm


name: nodules on distal aspect of left forearm


name: nodules on dorsal aspect of left forearm


name: nodules on medial aspect of left forearm


name: nodules on lateral aspect of left forearm


name: nodules on proximal aspect of both forearms


name: nodules on distal aspect of both forearms


name: nodules on volar aspect of both forearms


name: nodules on dorsal aspect of both forearms


name: nodules on medial aspect of both forearms


name: nodules on lateral aspect of both forearms


name: scales on right lateral aspect of foreskin


name: scales on left lateral aspect of foreskin


name: nodules on right lateral aspect of foreskin


name: nodules on left lateral aspect of foreskin


name: scales on proximal aspect of both forearms


name: scales on distal aspect of both forearms


name: scales on dorsal aspect of both forearms


name: scales on medial aspect of both forearms


name: scales on lateral aspect of both forearms


name: pustules on right lateral aspect of foreskin


name: pustules on left lateral aspect of foreskin


name: pustules on multiple fingers of right hand


name: pustules on multiple fingers of left hand


name: nodules on dorsal aspect of right middle finger


name: nodules on palmar aspect of right middle finger


name: nodules on medial aspect of right middle finger


name: nodules on lateral aspect of right middle finger


name: nodules on periungual aspect of right middle finger


name: nodules on proximal aspect of right ring finger


name: nodules on distal aspect of right ring finger


name: nodules on dorsal aspect of right ring finger


name: nodules on palmar aspect of right ring finger


name: nodules on medial aspect of right ring finger


name: nodules on lateral aspect of right ring finger


name: nodules on periungual aspect of right ring finger


name: nodules on proximal aspect of right little finger


name: nodules on distal aspect of right little finger


name: nodules on dorsal aspect of right little finger


name: nodules on palmar aspect of right little finger


name: nodules on medial aspect of right little finger


name: nodules on lateral aspect of right little finger


name: nodules on periungual aspect of right little finger


name: nodules on proximal aspect of left thumb


name: nodules on periungual aspect of left thumb


name: nodules on proximal aspect of left middle finger


name: nodules on proximal aspect of left index finger


name: nodules on distal aspect of left index finger


name: nodules on dorsal aspect of left index finger


name: nodules on palmar aspect of left index finger


name: nodules on medial aspect of left index finger


name: nodules on lateral aspect of left index finger


name: nodules on periungual aspect of left index finger


name: nodules on distal aspect of left middle finger


name: nodules on dorsal aspect of left middle finger


name: nodules on palmar aspect of left middle finger


name: nodules on medial aspect of left middle finger


name: nodules on lateral aspect of left middle finger


name: nodules on periungual aspect of left middle finger


name: nodules on proximal aspect of left ring finger


name: nodules on distal aspect of left ring finger


name: nodules on dorsal aspect of left ring finger


name: nodules on palmar aspect of left ring finger


name: nodules on medial aspect of left ring finger


name: nodules on lateral aspect of left ring finger


name: nodules on periungual aspect of left ring finger


name: nodules on proximal aspect of left little finger


name: nodules on distal aspect of left little finger


name: nodules on dorsal aspect of left little finger


name: nodules on palmar aspect of left little finger


name: nodules on medial aspect of left little finger


name: nodules on lateral aspect of left little finger


name: nodules on periungual aspect of left little finger


name: nodules on proximal aspect of both thumbs


name: nodules on lateral aspect of both thumbs


name: nodules on periungual aspect of both thumbs


name: nodules on proximal aspect of both index fingers


name: nodules on distal aspect of both index fingers


name: nodules on dorsal aspect of both index fingers


name: nodules on palmar aspect of both index fingers


name: nodules on medial aspect of both index fingers


name: nodules on lateral aspect of both index fingers


name: nodules on periungual aspect of both index fingers


name: nodules on proximal aspect of both middle fingers


name: nodules on distal aspect of both middle fingers


name: nodules on dorsal aspect of both middle fingers


name: nodules on palmar aspect of both middle fingers


name: nodules on medial aspect of both middle fingers


name: nodules on lateral aspect of both middle fingers


name: nodules on periungual aspect of both middle fingers


name: nodules on proximal aspect of both ring fingers


name: nodules on distal aspect of both ring fingers


name: nodules on dorsal aspect of both ring fingers


name: nodules on palmar aspect of both ring fingers


name: nodules on medial aspect of both ring fingers


name: nodules on lateral aspect of both ring fingers


name: nodules on periungual aspect of both ring fingers


name: nodules on proximal aspect of both little fingers


name: nodules on distal aspect of both little fingers


name: nodules on dorsal aspect of both little fingers


name: nodules on palmar aspect of both little fingers


name: nodules on medial aspect of both little fingers


name: nodules on lateral aspect of both little fingers


name: nodules on periungual aspect of both little fingers


name: patches on proximal aspect of both forearms


name: patches on distal aspect of both forearms


name: patches on volar aspect of both forearms


name: patches on dorsal aspect of both forearms


name: patches on medial aspect of both forearms


name: patches on lateral aspect of both forearms


name: patches on multiple fingers of right hand


name: patches on multiple fingers of left hand


name: patches on right lateral aspect of foreskin


name: patches on left lateral aspect of foreskin


name: plaques on right lateral aspect of foreskin


name: plaques on left lateral aspect of foreskin


name: plaques on proximal aspect of both forearms


name: plaques on distal aspect of both forearms


name: plaques on volar aspect of both forearms


name: plaques on dorsal aspect of both forearms


name: plaques on medial aspect of both forearms


name: plaques on lateral aspect of both forearms


name: vesicles on right lateral aspect of foreskin


name: vesicles on left lateral aspect of foreskin


name: vesicles on proximal aspect of both forearms


name: vesicles on distal aspect of both forearms


name: vesicles on volar aspect of both forearms


name: vesicles on dorsal aspect of both forearms


name: vesicles on medial aspect of both forearms


name: vesicles on lateral aspect of both forearms


name: vesicles on multiple fingers of left hand


name: vesicles on multiple fingers of right hand


name: papules on proximal aspect of both forearms


name: papules on distal aspect of both forearms


name: papules on volar aspect of both forearms


name: papules on dorsal aspect of both forearms


name: papules on medial aspect of both forearm


name: papules on lateral aspect of both forearms


name: macule on right lateral aspect of foreskin


name: macule on left lateral aspect of foreskin


name: macule on proximal aspect of both forearms


name: macule on distal aspect of both forearms


name: macule on dorsal aspect of both forearms


name: macule on medial aspect of both forearms


name: macule on lateral aspect of both forearms


name: macule on multiple fingers of right hand


name: pain level by West Haven-Yale multidimensional pain inventory


name: WHYMPI pain experience subscale: support score


name: WHYMPI pain experience subscale: interference score


name: WHYMPI pain experience subscale: pain severity score


name: WHYMPI pain experience subscale: life-control score


name: WHYMPI significant-other responses subscale


name: WHYMPI significant-other responses subscale: negative responses


name: WHYMPI significant-other responses subscale: solicitous responses


name: WHYMPI significant-other responses subscale: distracting responses


name: Angiotensin II receptor antagonist (disposition)


name: WHYMPI daily activities subscale: household chores score


name: WHYMPI daily activities subscale: outdoor work score


name: WHYMPI daily activities subscale: activities away from home score


name: WHYMPI daily activities subscale: social activities score


name: WHYMPI daily activities subscale: general activity score


name: WHYMPI pain experience subscale: affective distress score


name: prescription drug monitoring in urine by definitive tandem mass spectrometry with chromatography


name: narrow density LDL cholesterol in serum or plasma


name: LVEF by 2D modified ultrasound, apical 2-chamber view and calculated by single plane method of disks


name: LVEF by 2D modified ultrasound, apical 4-chamber view and calculated by single plane method of disks


name: patient info entered in system, next exam date, follow-up process


name: substance use therapy - harm reduction program


name: papule on the face angular commissure both


name: hepatitis B e-antigen and e-antibody panel in serum


name: alpha lipoprotein entitic length in serum or plasma


name: angiography of right lower extremity: calcification


name: angiography of right femoral artery: calcification


name: angiography of right common femoral artery: calcification


name: angiography of right profunda femoral artery: calcification


name: angiography of right superficial femoral artery: calcification


name: angiography of right popliteal artery: calcification


name: angiography of left lower extremity: calcification


name: angiography of left femoral artery: calcification


name: angiography of left common femoral artery: calcification


name: angiography of left profunda femoral artery: calcification


name: angiography of left superficial femoral artery: calcification


name: angiography of both lower extremities: calcification


name: angiography of bilateral femoral arteries: calcification


name: angiography of bilateral common femoral arteries: calcification


name: angiography of bilateral profunda femoral arteries: calcification


name: angiography of bilateral superficial femoral arteries: calcification


name: angiography of femoral artery: calcification


name: angiography of common femoral artery: calcification


name: angiography of profunda femoral artery: calcification


name: angiography of superficial femoral artery: calcification


name: angiography iliac calcification right common


name: angiography iliac calcification right external


name: angiography iliac calcification right internal


name: angiography iliac calcification left common


name: angiography iliac calcification left external


name: angiography iliac calcification left internal


name: angiography iliac calcification bilateral


name: angiography iliac calcification bilateral common


name: angiography iliac calcification bilateral external


name: angiography iliac calcification bilateral internal


name: angiography iliac calcification external


name: angiography iliac calcification internal


name: skin lesion culture for herpes simplex type II


name: definitive chromatography with mass spectrometry of 120 or more urine analytes for interaction detection


name: saliva analysis rx drug monitor liquid chromatography w/ mass spectrometry


name: quantitative assessment of three urine metabolites by liquid chromatography with tandem mass spectrometry


name: NAA with probe detection for respiratory syncytial virus


name: gene rearrangement analysis by whole genome next-generation sequencing


name: gene rearrangement analysis by whole genome next-generation sequencing, whole blood or bone marrow


name: gene rearrangement analysis by whole genome next-generation sequencing, whole blood


name: gene rearrangement analysis by whole genome next-generation sequencing, fresh or frozen tissue or cells


name: DNA PCR amplification and probe hybridization


name: DNA PCR amplification and probe hybridization of bacterial culture colonies


name: RBC antigen typing in whole blood, 35 antigens from 11 blood groups


name: Helicobacter pylori detection and antibiotic resistance analysis


name: Helicobacter pylori detection and antibiotic resistance analysis by next generation sequencing panel


name: molecular diagnostics erbb2 copy number variation identified by fish


name: ERBB2 copy number variation ID by FISH using dielectrophoresis sorting


name: whole genome sequencing for bacterial infectious disease typing


name: molecular diagnostics drug metabolism analysis by real-time pcr


name: drug metabolism analysis by real-time PCR 22 drug metabolism and transporter genes


name: PCR amplification for fusion transcript detection


name: PCR amplification for fusion transcript detection for BCR/ABL1


name: PCR amplification and sequence analysis of JAK2 exons 12-14


name: biochemical genetic studies serum proteins


name: biochemical genetic studies five serum proteins


name: multianalyte assays with algorithmic analyses for oncology with real-time RT-PCR mRNA expression analysis


name: gene expression profile by real-time PCR of 3 genes


name: gene expression profile by real-time PCR of 3 genes in urine


name: mild persistent asthma with acute severe exacerbation with allergic rhinitis


name: moderate persistent asthma with acute severe exacerbation with allergic rhinitis


name: severe persistent asthma with acute severe exacerbation with allergic rhinitis


name: acute exacerbation of asthma with allergic rhinitis


name: fecal analysis using noninvasive colorectal cancer DNA test with occult blood screening


name: fecal analysis using noninvasive colorectal cancer DNA test with occult blood screening, narrative interpretation


name: DXA of radius and ulna bone density T-score


name: human papilloma virus in cervix, DNA interpretation


name: human papilloma virus in cervix, 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA interpretation


name: NAA with probe detection for human papilloma virus DNA


name: NAA with probe detection for human papilloma virus 16 DNA


name: NAA with probe detection for human papilloma virus 16 DNA in cervix


name: NAA with probe detection for human papilloma virus 18 DNA


name: NAA with probe detection for human papilloma virus 18 DNA in cervix


name: glucose monitor 72+ hrs continuous via subcutaneous sensor office-provided equip


name: glucose monitoring 72+ hours by continuous recording and subcutaneous sensor using patient-provided equipment


name: acetylated LDL cholesterol in serum or plasma


name: pulmonary stress testing for bronchospasm


name: retinal polarization scan for bilateral ocular screening


name: external patient-demand ECG event recorder, in-office connection


name: external patient-demand ECG event recorder, physician review and interpretation with patient-generated event


name: mcg multichannel fetal record, scan, & raw electronic signal transfer


name: mcg multichannel fetal signal extraction, analysis, and result


name: mcg multichannel fetal supervision, review, interpretation


name: mcg multichannel fetal review, interpretation, report


name: optical coherence tomography middle ear right


name: optical coherence tomography middle ear left


name: optical coherence tomography middle ear bilateral


name: optical coherence tomography skin initial lesion


name: optical coherence tomography skin additional lesion


name: CT angiography of coronary arteries with fractional flow reserve measurement


name: coronary CT angiography with fractional flow reserve measurement, data preparation and transmission


name: coronary CT angiography with fluid dynamics analysis, hyperemia simulation, fractional flow reserve estimation


name: coronary CT angiography, anatomical data comparison with fractional flow reserve estimation, interpretation and report


name: myocardial PET, absolute quantitation of perfusion


name: LVEF by 3D ultrasound image segmentation


name: LVEF by M-mode ultrasound and calculation by cube method


name: rectal culture for Chlamydia trachomatis


name: antigen detection for HPV, five or more high-risk types


name: NAA with probe detection for Chlamydia trachomatis DNA in rectum


name: NAA with probe detection for Chlamydia trachomatis rRNA in rectum


name: NAA with probe detection for Chlamydia trachomatis + Neisseria gonorrhoeae rRNA


name: NAA with probe detection for Chlamydia trachomatis + Neisseria gonorrhoeae rRNA in cervix


name: NAA with probe detection for Chlamydia trachomatis + Neisseria gonorrhoeae rRNA in rectum


name: NAA with probe detection for Chlamydia trachomatis + Neisseria gonorrhoeae rRNA in urine


name: NAA with probe detection for Chlamydia trachomatis + Neisseria gonorrhoeae rRNA in vagina


name: photodynamic therapy by external light provided by health care professional


name: intensive diabetes prevention program individual, online


name: musculoskeletal procedures injection autologous white blood cell concentrate


name: eye surg insert ant segment aqueous drain device internal supraciliary


name: retinal electrode array initial programming


name: mitral valve implantation transcatheter prosthetic


name: mitral valve implantation transcatheter prosthetic percutaneous approach


name: mitral valve implantation transcatheter prosthetic transthoracic exposure


name: preparation of donor lung prior to implantation with cannulation to ex vivo organ perfusion system


name: initiation and monitoring of donor lung organ perfusion system prior to implantation


name: initiation and monitoring of donor lung organ perfusion system prior to implantation, first 2 hours in sterile field


name: initiation and monitoring of donor lung organ perfusion system prior to implantation, each additional hour in sterile field


name: cystourethroscopy with mechanical dilation and therapeutic drug delivery


name: cystourethroscopy with mechanical dilation and therapeutic drug delivery for urethral stricture or stenosis


name: robotic-assisted laparoscopic total hysterectomy


name: robotic-assisted laparoscopic radical hysterectomy


name: debridement of premalignant hyperkeratotic lesion


name: debridement of premalignant hyperkeratotic lesion followed by photodynamic therapy by external light


name: ablative laser treatment fractional resurfacing


name: ablative fractional resurfacing burn or scar


name: ablative fractional resurfacing burn or scar first 100 cm2


name: ablative fractional resurfacing of burn or scar, each additional 100 cm2


name: ablative fractional resurfacing burn/scar 1% body surface area infant/child


name: ablative fractional resurfacing of burn or scar, each additional 1% body surface area of infant/child


name: ablative fractional resurfacing open wound


name: ablative fractional resurfacing open wound first 20 cm2 or less


name: ablative fractional resurfacing of open wound, each additional 20 cm2


name: autologous adipose-derived regenerative cell therapy


name: autologous adipose-derived regenerative cell therapy for scleroderma of hands, multiple injections


name: environment: intermediate care hospital for intellectually disabled


name: acetaminophen + aspirin + dextromethorphan + diphenhydramine


name: {1 (acetaminophen 32.5 MG/ML / diphenhydramine hydrochloride 1.25 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution) / 1 (dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML Oral Solution) } Pack


name: prothrombin time in control platelet-poor plasma by coagulation assay


name: arterial cord blood PaCO2 adjusted to patient's actual temperature


name: arterial cord blood PaO2 adjusted to patient's actual temperature


name: first and second trimester integrated maternal serum or plasma screening panel


name: first and second trimester integrated maternal interpretation


name: protein electrophoresis panel in serum or plasma


name: albumin / total protein in serum or plasma by electrophoresis


name: alpha 1 globulin/total protein in serum or plasma by electrophoresis


name: alpha 2 globulin/total protein in serum or plasma by electrophoresis


name: beta globulin/total protein in serum or plasma by electrophoresis


name: clozapine and norclozapine panel in serum or plasma


name: tissue transglutaminase IgA antibody in serum


name: tissue transglutaminase IgG antibody in serum


name: 24 hour renal creatinine clearance panel


name: GFR predicted by cystatin-based formula, serum or plasma


name: PTA of right common iliac artery, initial vessel


name: PTA of right common iliac artery, initial vessel, with atherectomy


name: PTA of right common iliac artery, initial vessel, with stent


name: PTA of right common iliac artery, initial vessel, with drug-eluting stent


name: PTA of right common iliac artery, initial vessel, with atherectomy and stent


name: PTA of right common iliac artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of right common iliac artery, each additional vessel


name: PTA of right common iliac artery, each additional vessel, with atherectomy


name: PTA of right common iliac artery, each additional vessel, with stent


name: PTA of right common iliac artery, each additional vessel, with drug-eluting stent


name: PTA of right common iliac artery, each additional vessel, with atherectomy and stent


name: PTA of right common iliac artery, each additional vessel, with atherectomy and drug-eluting stent


name: PTA of right external iliac artery, initial vessel


name: PTA of right external iliac artery, initial vessel, with atherectomy


name: PTA of right external iliac artery, initial vessel, with stent


name: PTA of right external iliac artery, initial vessel, with drug-eluting stent


name: PTA of right external iliac artery, initial vessel, with atherectomy and stent


name: PTA of right external iliac artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of right external iliac artery, each additional vessel


name: PTA of right external iliac artery, each additional vessel, with atherectomy


name: PTA of right external iliac artery, each additional vessel, with stent


name: PTA of right external iliac artery, each additional vessel, with drug-eluting stent


name: PTA of right external iliac artery, each additional vessel, with atherectomy and stent


name: PTA of right external iliac artery, each additional vessel, with atherectomy and drug-eluting stent


name: PTA of right internal iliac artery, initial vessel


name: PTA of right internal iliac artery, initial vessel, with atherectomy


name: PTA of right internal iliac artery, initial vessel, with stent


name: PTA of right internal iliac artery, initial vessel, with drug-eluting stent


name: PTA of right internal iliac artery, initial vessel, with atherectomy and stent


name: PTA of right internal iliac artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of right internal iliac artery, each additional vessel


name: PTA of right internal iliac artery, each additional vessel, with atherectomy


name: PTA of right internal iliac artery, each additional vessel, with stent


name: PTA of right internal iliac artery, each additional vessel, with drug-eluting stent


name: PTA of right internal iliac artery, each additional vessel, with atherectomy and stent


name: PTA of right internal iliac artery, each additional vessel, with atherectomy and drug-eluting stent


name: PTA of left common iliac artery, initial vessel


name: PTA of left common iliac artery, initial vessel, with atherectomy


name: PTA of left common iliac artery, initial vessel, with stent


name: PTA of left common iliac artery, initial vessel, with drug-eluting stent


name: PTA of left common iliac artery, initial vessel, with atherectomy and stent


name: PTA of left common iliac artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of left common iliac artery, each additional vessel


name: PTA of left common iliac artery, each additional vessel, with atherectomy


name: PTA of left common iliac artery, each additional vessel, with stent


name: PTA of left common iliac artery, each additional vessel, with drug-eluting stent


name: PTA of left common iliac artery, each additional vessel, with atherectomy and stent


name: PTA of left common iliac artery, each additional vessel, with atherectomy and drug-eluting stent


name: PTA of left external iliac artery, initial vessel


name: PTA of left external iliac artery, initial vessel, with atherectomy


name: PTA of left external iliac artery, initial vessel, with stent


name: PTA of left external iliac artery, initial vessel, with drug-eluting stent


name: PTA of left external iliac artery, initial vessel, with atherectomy and stent


name: PTA of left external iliac artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of left external iliac artery, each additional vessel


name: PTA of left external iliac artery, each additional vessel, with atherectomy


name: PTA of left external iliac artery, each additional vessel, with stent


name: PTA of left external iliac artery, each additional vessel, with drug-eluting stent


name: PTA of left external iliac artery, each additional vessel, with atherectomy and stent


name: PTA of left external iliac artery, each additional vessel, with atherectomy and drug-eluting stent


name: PTA of left internal iliac artery, initial vessel


name: PTA of left internal iliac artery, initial vessel, with atherectomy


name: PTA of left internal iliac artery, initial vessel, with stent


name: PTA of left internal iliac artery, initial vessel, with drug-eluting stent


name: PTA of left internal iliac artery, initial vessel, with atherectomy and stent


name: PTA of left internal iliac artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of left internal iliac artery, each additional vessel


name: PTA of left internal iliac artery, each additional vessel, with atherectomy


name: PTA of left internal iliac artery, each additional vessel, with stent


name: PTA of left internal iliac artery, each additional vessel, with drug-eluting stent


name: PTA of left internal iliac artery, each additional vessel, with atherectomy and stent


name: PTA of left internal iliac artery, each additional vessel, with atherectomy and drug-eluting stent


name: PTA of right iliac artery, initial vessel


name: PTA of right iliac artery, each additional vessel


name: PTA of left iliac artery, initial vessel


name: PTA of left iliac artery, each additional vessel


name: PTA of right popliteal artery, above knee


name: PTA of right popliteal artery, above knee, initial vessel


name: PTA of right popliteal artery, above knee, initial vessel with atherectomy


name: PTA of right popliteal artery, above knee, initial vessel with stent


name: PTA of right popliteal artery, above knee, initial vessel with drug-eluting stent


name: PTA of right popliteal artery, above knee, initial vessel with atherectomy and stent


name: PTA of right popliteal artery, above knee, initial vessel with atherectomy and drug-eluting stent


name: PTA of right popliteal artery, above knee, additional vessel


name: PTA of right popliteal artery, above knee, additional vessel with atherectomy


name: PTA of right popliteal artery, above knee, additional vessel with stent


name: PTA of right popliteal artery, above knee, additional vessel with drug-eluting stent


name: PTA of right popliteal artery, above knee, additional vessel with atherectomy and stent


name: PTA of right popliteal artery, above knee, additional vessel with atherectomy and drug-eluting stent


name: PTA of right popliteal artery, below knee


name: PTA of right popliteal artery, below knee, initial vessel


name: PTA of right popliteal artery, below knee, initial vessel with atherectomy


name: PTA of right popliteal artery, below knee, initial vessel with stent


name: PTA of right popliteal artery, below knee, initial vessel with drug-eluting stent


name: PTA of right popliteal artery, below knee, initial vessel with atherectomy and stent


name: PTA of right popliteal artery, below knee, initial vessel with atherectomy and drug-eluting stent


name: PTA of right popliteal artery, below knee, additional vessel


name: PTA of right popliteal artery, below knee, additional vessel with atherectomy


name: PTA of right popliteal artery, below knee, additional vessel with stent


name: PTA of right popliteal artery, below knee, additional vessel with drug-eluting stent


name: PTA of right popliteal artery, below knee, additional vessel with atherectomy and stent


name: PTA of right popliteal artery, below knee, additional vessel with atherectomy and drug-eluting stent


name: PTA of left popliteal artery, above knee


name: PTA of left popliteal artery, above knee, initial vessel


name: PTA of left popliteal artery, above knee, initial vessel with atherectomy


name: PTA of left popliteal artery, initial vessel with stent


name: PTA of left popliteal artery, initial vessel with drug-eluting stent


name: PTA of left popliteal artery, initial vessel with atherectomy and stent


name: PTA of left popliteal artery, initial vessel with atherectomy and drug-eluting stent


name: PTA of left popliteal artery, above knee, additional vessel


name: PTA of left popliteal artery, above knee, additional vessel with atherectomy


name: PTA of left popliteal artery, above knee, additional vessel with stent


name: PTA of left popliteal artery, above knee, additional vessel with drug-eluting stent


name: PTA of left popliteal artery, above knee, additional vessel with atherectomy and stent


name: PTA of left popliteal artery, above knee, additional vessel with atherectomy and drug-eluting stent


name: PTA of left popliteal artery, below knee


name: PTA of left popliteal artery, below knee, initial vessel


name: PTA of left popliteal artery, below knee, initial vessel with atherectomy


name: PTA of left popliteal artery, below knee, initial vessel with stent


name: PTA of left popliteal artery, below knee, initial vessel with drug-eluting stent


name: PTA of left popliteal artery, below knee, initial vessel with atherectomy and stent


name: PTA of left popliteal artery, below knee, initial vessel with atherectomy and drug-eluting stent


name: PTA of left popliteal artery, below knee, additional vessel


name: PTA of left popliteal artery, below knee, additional vessel with atherectomy


name: PTA of left popliteal artery, below knee, additional vessel with stent


name: PTA of left popliteal artery, below knee, additional vessel with drug-eluting stent


name: PTA of left popliteal artery, below knee, additional vessel with atherectomy and stent


name: PTA of left popliteal artery, below knee, additional vessel with atherectomy and drug-eluting stent


name: PTA of right popliteal artery, initial vessel


name: PTA of left popliteal artery, initial vessel


name: PTA of popliteal artery, additional vessel


name: PTA of right popliteal artery, additional vessel


name: PTA of left popliteal artery, additional vessel


name: PTA of right tibioperoneal, initial vessel


name: PTA of right tibioperoneal, initial vessel, with atherectomy


name: PTA of right tibioperoneal, initial vessel, with stent


name: PTA of right tibioperoneal, initial vessel, with drug-eluting stent


name: PTA of right tibioperoneal, initial vessel, with atherectomy and stent


name: PTA of right tibioperoneal, initial vessel, with atherectomy and drug-eluting stent


name: PTA of right tibioperoneal, additional vessel


name: PTA of right tibioperoneal, additional vessel, with atherectomy


name: PTA of right tibioperoneal, additional vessel, with stent


name: PTA of right tibioperoneal, additional vessel, with drug-eluting stent


name: PTA of right tibioperoneal, additional vessel, with atherectomy and stent


name: PTA of right tibioperoneal, additional vessel, with atherectomy and drug-eluting stent


name: PTA of left tibioperoneal, initial vessel


name: PTA of left tibioperoneal, initial vessel, with atherectomy


name: PTA of left tibioperoneal, initial vessel, with stent


name: PTA of left tibioperoneal, initial vessel, with drug-eluting stent


name: PTA of left tibioperoneal, initial vessel, with atherectomy and stent


name: PTA of left tibioperoneal, initial vessel, with atherectomy and drug-eluting stent


name: PTA of left tibioperoneal, each additional vessel


name: PTA of left tibioperoneal, each additional vessel, with atherectomy


name: PTA of left tibioperoneal, each additional vessel, with stent


name: PTA of left tibioperoneal, each additional vessel, with drug-eluting stent


name: PTA of left tibioperoneal, each additional vessel, with atherectomy and stent


name: PTA of left tibioperoneal, each additional vessel, with atherectomy and drug-eluting stent


name: PTA of right peroneal artery, initial vessel


name: PTA of right peroneal artery, initial vessel, with atherectomy


name: PTA of right peroneal artery, initial vessel, with stent


name: PTA of right peroneal artery, initial vessel, with drug-eluting stent


name: PTA of right peroneal artery, initial vessel, with atherectomy and stent


name: PTA of right peroneal artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of right peroneal artery, additional vessel


name: PTA of right peroneal artery, additional vessel, with atherectomy


name: PTA of right peroneal artery, additional vessel, with stent


name: PTA of right peroneal artery, additional vessel, with drug-eluting stent


name: PTA of right peroneal artery, additional vessel, with atherectomy and stent


name: PTA of right peroneal artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of left peroneal artery, initial vessel


name: PTA of left peroneal artery, initial vessel, with atherectomy


name: PTA of left peroneal artery, initial vessel, with stent


name: PTA of left peroneal artery, initial vessel, with drug-eluting stent


name: PTA of left peroneal artery, initial vessel, with atherectomy and stent


name: PTA of left peroneal artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of left peroneal artery, each additional vessel


name: PTA of left peroneal artery, each additional vessel, with atherectomy


name: PTA of left peroneal artery, each additional vessel, with stent


name: PTA of left peroneal artery, additional vessel, with drug-eluting stent


name: PTA of left peroneal artery, each additional vessel, with atherectomy and stent


name: PTA of left peroneal artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of peroneal artery, each additional vessel


name: Borrelia burgdorferi panel in serum by immunoblot


name: Borrelia burgdorferi IgG panel in serum by immunoblot


name: Borrelia burgdorferi IgM panel in serum by immunoblot


name: hepatitis B core and surface antibody, surface antigen panel in serum


name: hepatitis C FibroSURE (TM) panel in serum or plasma


name: opiates panel in meconium, confirmatory method


name: protein electrophoresis and immunoglobulins panel in serum


name: 25-hydroxyvitamin D2 + 25-hydroxyvitamin D3 in serum or plasma


name: calcidiol + calciferol in serum or plasma, interpretation


name: beta 1 globulin in serum or plasma by electrophoresis


name: beta 1 globulin / total protein in serum or plasma by electrophoresis


name: beta 2 globulin in serum or plasma by electrophoresis


name: beta 2 globulin / total protein in serum or plasma by electrophoresis


name: gamma globulin/total protein in serum or plasma by electrophoresis


name: monoclonal protein / total protein in serum or plasma by electrophoresis


name: lipoprotein fractions in serum or plasma by electrophoresis, interpretation


name: renal creatinine clearance 24 hour panel adjusted for body surface area


name: creatinine and GFR predicted panel in serum or plasma


name: serum immunoblot for Borrelia burgdorferi antibody


name: serum immunoblot for Borrelia burgdorferi IgG antibody


name: serum immunoblot for Borrelia burgdorferi 18kD IgG antibody


name: serum immunoblot for Borrelia burgdorferi 23kD IgG antibody


name: serum immunoblot for Borrelia burgdorferi 28kD IgG antibody


name: serum immunoblot for Borrelia burgdorferi 30kD IgG antibody


name: serum immunoblot for Borrelia burgdorferi 39kD IgG antibody


name: serum immunoblot for Borrelia burgdorferi 41kD IgG antibody


name: serum immunoblot for Borrelia burgdorferi 45kD IgG antibody


name: serum immunoblot for Borrelia burgdorferi 58kD IgG antibody


name: serum immunoblot for Borrelia burgdorferi 66kD IgG antibody


name: serum immunoblot for Borrelia burgdorferi 93kD IgG antibody


name: Borrelia burgdorferi IgG antibody band pattern interpretation in serum by immunoblot


name: serum immunoblot for Borrelia burgdorferi IgM antibody


name: serum immunoblot for Borrelia burgdorferi 23kD IgM antibody


name: serum immunoblot for Borrelia burgdorferi 39kD IgM antibody


name: serum immunoblot for Borrelia burgdorferi 41kD IgM antibody


name: Borrelia burgdorferi IgM antibody band pattern interpretation in serum by immunoblot


name: serum immunoblot for Borrelia burgdorferi IgG + IgM antibody


name: serum immunoblot for Borrelia burgdorferi IgG + IgM antibody, interpretation


name: serum immunoblot Borrelia burgdorferi antibody, interpretation


name: serum enzyme immunoassay for Borrelia burgdorferi IgG + IgM, interpretation


name: serum Hepatitis A antibody IgM + total, interpretation


name: PTA of right common femoral artery, initial vessel


name: PTA of right common femoral artery, initial vessel, with atherectomy


name: PTA of right common femoral artery, initial vessel, with stent


name: PTA of right common femoral artery, initial vessel, with drug-eluting stent


name: PTA of right common femoral artery, initial vessel, with atherectomy and stent


name: PTA of right common femoral artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of right common femoral artery, additional vessel


name: PTA of right common femoral artery, additional vessel, with atherectomy


name: PTA of right common femoral artery, additional vessel, with stent


name: PTA of right common femoral artery, additional vessel, with drug-eluting stent


name: PTA of right common femoral artery, additional vessel, with atherectomy and stent


name: PTA of right common femoral artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of right profunda femoral artery, initial vessel


name: PTA of right profunda femoral artery, initial vessel, with atherectomy


name: PTA of right profunda femoral artery, initial vessel, with stent


name: PTA of right profunda femoral artery, initial vessel, with drug-eluting stent


name: PTA of right profunda femoral artery, initial vessel, with atherectomy and stent


name: PTA of right profunda femoral artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of right profunda femoral artery, additional vessel


name: PTA of right profunda femoral artery, additional vessel, with atherectomy


name: PTA of right profunda femoral artery, additional vessel, with stent


name: PTA of right profunda femoral artery, additional vessel, with drug-eluting stent


name: PTA of right profunda femoral artery, additional vessel, with atherectomy and stent


name: PTA of right profunda femoral artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of right superficial femoral artery, initial vessel


name: PTA of right superficial femoral artery, initial vessel, with atherectomy


name: PTA of right superficial femoral artery, initial vessel, with stent


name: PTA of right superficial femoral artery, initial vessel, with drug-eluting stent


name: PTA of right superficial femoral artery, initial vessel, with atherectomy and stent


name: PTA of right superficial femoral artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of right superficial femoral artery, additional vessel


name: PTA of right superficial femoral artery, additional vessel, with atherectomy


name: PTA of right superficial femoral artery, additional vessel, with stent


name: PTA of right superficial femoral artery, additional vessel, with drug-eluting stent


name: PTA of right superficial femoral artery, additional vessel, with atherectomy and stent


name: PTA of right superficial femoral artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of left common femoral artery, initial vessel


name: PTA of left common femoral artery, initial vessel, with atherectomy


name: PTA of left common femoral artery, initial vessel, with stent


name: PTA of left common femoral artery, initial vessel, with drug-eluting stent


name: PTA of left common femoral artery, initial vessel, with atherectomy and stent


name: PTA of left common femoral artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of left common femoral artery, additional vessel


name: PTA of left common femoral artery, additional vessel, with atherectomy


name: PTA of left common femoral artery, additional vessel, with stent


name: PTA of left common femoral artery, additional vessel, with drug-eluting stent


name: PTA of left common femoral artery, additional vessel, with atherectomy and stent


name: PTA of left common femoral artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of left profunda femoral artery, initial vessel


name: PTA of left profunda femoral artery, initial vessel, with atherectomy


name: PTA of left profunda femoral artery, initial vessel, with stent


name: PTA of left profunda femoral artery, initial vessel, with drug-eluting stent


name: PTA of left profunda femoral artery, initial vessel, with atherectomy and stent


name: PTA of left profunda femoral artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of left profunda femoral artery, additional vessel


name: PTA of left profunda femoral artery, additional vessel, with atherectomy


name: PTA of left profunda femoral artery, additional vessel, with stent


name: PTA of left profunda femoral artery, additional vessel, with drug-eluting stent


name: PTA of left profunda femoral artery, additional vessel, with atherectomy and stent


name: PTA of left profunda femoral artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of left superficial femoral artery, initial vessel


name: PTA of left superficial femoral artery, initial vessel, with atherectomy


name: PTA of left superficial femoral artery, initial vessel, with stent


name: PTA of left superficial femoral artery, initial vessel, with drug-eluting stent


name: PTA of left superficial femoral artery, initial vessel, with atherectomy and stent


name: PTA of left superficial femoral artery, initial vessel, with atherectomy and drug-eluting stent


name: PTA of left superficial femoral artery, additional vessel


name: PTA of left superficial femoral artery, additional vessel, with atherectomy


name: PTA of left superficial femoral artery, additional vessel, with stent


name: PTA of left superficial femoral artery, additional vessel, with drug-eluting stent


name: PTA of left superficial femoral artery, additional vessel, with atherectomy and stent


name: PTA of left superficial femoral artery, additional vessel, with atherectomy and drug-eluting stent


name: PTA of right femoral artery, initial vessel


name: PTA of right femoral artery, additional vessel


name: PTA of left femoral artery, initial vessel


name: PTA of left femoral artery, additional vessel


name: PTA of femoral artery, additional vessel


name: Aspartic proteinase inhibitor (disposition)


name: Benzodiazepine receptor antagonist (disposition)


name: Beta adrenergic receptor antagonist (disposition)


name: {21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [VyLibra 28 Day]


name: {7 (ethinyl estradiol 0.035 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Tri-VyLibra 28 Day]


name: RBC morphology, normochromic red blood cells


name: Beta adrenergic receptor agonist (disposition)


name: Light colored irises (blue, green, light brown)


name: Numerous tiny gray flecks, less than 100 micrometers in diameter, limited to anterior 20% of stroma


name: Disc-shaped, circular, or wreath-like gray-white opacities, 0.2 to 1.5 mm in diameter, in Bowman layer and adjacent anterior stroma


name: Hyperreflective polymorphous intraepithelial opacities seen on confocal microscopy


name: Destruction of Bowman layer and subepithelial nerve plexus in some areas


name: Diffuse accumulation of extracellular matrix in anterior stroma adjacent to areas of Bowman layer destruction


name: Needle-like opacities, primarily in anterior stroma


name: Increased granular cell layer with vacuolization and clumping of keratohyaline granules


name: Hyperkeratotic plaques (well demarcated symmetric geographic)


name: Hyperkeratosis, severe generalized hystrix-like


name: Dense eosinophilic keratotic band just above granular layer


name: Lymphohistiocytic infiltrate in upper dermis, mild


name: Asymptomatic hamartoma-like lesions in dorsal medulla


name: Asymptomatic hamartoma-like lesions in ventral pons


name: Origin of facial nerves more anterior than normal


name: Enlargement of origin of vestibulocochlear nerves


name: Central corneal endothelial guttata and folds


name: Low luteinizing hormone (LH, see 152780) levels


name: Low follicle-stimulating hormone (FSH, see 136530) levels


name: Sparse scalp hair (slow, diffuse hair loss begins in middle of first decade)


name: Catagen and telogen hairs disappear in terminal stage


name: Skin tags containing cartilage on forehead


name: Eruptive milia (benign keratinous cysts on face and upper trunk)


name: Male infertility (in individuals with bilateral cryptorchidism)


name: Numbness of 5th finger and ulnar half of 4th finger


name: Upslanting or downslanting palpebral fissures


name: Truncal obesity developing in midchildhood


name: Recurrent infections (associated with hypogammaglobulinemia)


name: Enlargement of the proximal third of the clavicle


name: Lack of pneumatization of the sphenoidal sinuses


name: Increased bone density of the vertebral body end plates


name: Enlargement of the distal metaphyses of the antebrachial bones


name: Enlargement of the long bones, which are shortened


name: Enlargement of the proximal and distal metaphyses of the tibia and fibula


name: Erythematous, irregular macular lesions without induration on dorsum of hands, neck, and trunk


name: Limb malformations (particularly of the arms)


name: Perithalamic and periventricular calcifications


name: Congenital fiber-type disproportion seen on muscle biopsy


name: Increased numbers hypotrophic type I fibers


name: Mild mental retardation Decrease global brain volume


name: Smaller age- and head size-adjusted areas of posterior fossa, vermis, corpus callosum, and pons than healthy controls


name: Larger cerebrum-vermis ratio than the healthy controls


name: Smaller occipito-frontal head circumference than controls


name: Portal inflammation, mild to moderate Portal fibrosis, mild


name: Patchy to diffuse macrovesicular steatosis


name: Prominent tricarboxylic acid cycle metabolites in urine (particularly fumarate)


name: Abnormally high delta(4)-A to T ratio in plasma


name: Underdeveloped cerebral gyri (recessive)


name: Upslanting palpebral fissures (recessive)


name: Delayed eruption of dentition (recessive)


name: Axillary acanthosis nigricans (recessive)


name: Narrowing of pulmonary branch arteries (recessive)


name: Continuation of inferior vena cava to azygos vein (recessive)


name: Ventricular septal defect Pulmonary valvular stenosis


name: XIAP, 3-BP DEL, 1045GAG (dbSNP rs199683465)


name: Pigmentary skin anomalies (on face and scalp)


name: Decreased TNF-alpha release from monocytes after stimulation due to defective NOD2 signaling


name: Increased sensitivity of T cells to activation-induced cell death (AICD)


name: Microcephaly, progressive (variable, -2 to -9 SD)


name: Continuous centrotemporal activity seen on EEG


name: Continuous frontal spike and slow-wave activity


name: Continuous spike and slow-wave activity during sleep


name: Severe nearsightedness in early childhood


name: Spherical refraction equal to or greater than -6.00 in each meridian


name: Aganglionosis (sometimes confined to descending or rectosigmoid colon)


name: REST, 2-BP DEL, 2865AA (dbSNP SCV000579327)


name: Normal to high urinary 5-hydroxyindoleacetic acid (5-HIAA) levels


name: Unidentified bright objects seen on brain MRI


name: Reduced to absent foveal outer nuclear layer seen on OCT


name: Reduced to absent foveal inner segment/outer segment layer seen on OCT


name: Segmental irregularities and narrowing of intrahepatic bile ducts


name: Mild proliferation and inflammation of bile ducts


name: Salt-and-pepper appearance of peripheral retina


name: Cone-rod dystrophy seen on electroretinography


name: Reduced to nonrecordable electroretinograms


name: Thinning of photoreceptor layer outside of the macular area


name: Disorganization of photoreceptor layer outside the macular area


name: Bilateral small-sized cysts of the choroid plexus


name: Paraventricular cyst in the area of the caudate nucleus


name: Leukomalacia along the walls of the occipital horns of lateral ventricles


name: Constriction ring in the proximal part of the penis


name: Thin hair shafts with no characteristic abnormality


name: Vertical sclerotic striations in vertebral bodies


name: Curvilinear sclerotic striations in ilia


name: Vertical sclerotic striations of proximal femora


name: Vertical sclerotic striations of proximal tibia


name: Vertical sclerotic striations of distal tibial metaphyses


name: Diffuse sclerosis of long bone epiphyses


name: Relative osteopenia of long bone metaphyses


name: Diffuse trabecular coarseness of carpals


name: Diffuse trabecular coarseness of metacarpals


name: Cortical hyperostosis of second and third metacarpals, mild


name: Sclerosis of epiphyses of tubular bones, mild


name: Small anterior pituitary gland with poorly visible stalk


name: Corneal decompensation secondary to endothelial dystrophy


name: Endothelial cell multilayering with desmosomal intercellular attachments seen on ultrastructural analysis of corneal material


name: Mulberry-like vesicles develop with the epithelial transformation of endothelial cells


name: Respiratory difficulties secondary to neurodegenerative disease


name: Short stature, disproportionate (adult height 26-28 inches)


name: Marked reduction of mature hair follicles


name: Coarse, wiry, and twisted scalp hair develops in childhood


name: Scalp forehead and parietal areas remain bald or sparse


name: Limitation of carpal and interphalangeal joint movement, progressive


name: Limitation of tarsal and interphalangeal joint movement, progressive


name: Bone spicule pigment deposits in periphery and midperiphery


name: Bone spicule pigment deposits in midperiphery of retina


name: Loss of rod and cone responses seen on ERG


name: Acne inversa (predominantly affecting armpit, groin, inner thigh, perianal and perineal, submammary, and buttock regions)


name: Reticulate pigmentation in flexural areas


name: Reticulate pigmentation of face, trunk, and neck


name: Downward elongations of rete ridges in reticulated pattern


name: Red blood cells lack some ('Dr(A-)') or all ('Inab') of the Cromer blood group antigens


name: Lack of secondary aggregation response of platelets


name: Skin pigment dilution relative to unaffected family members


name: Hair pigment dilution relative to unaffected family members


name: Skin pigment dilution, mild to severe, relative to unaffected family members


name: Accumulation of ceroid pigment in perivascular macrophages


name: Hair pigment, mild to severe, dilution relative to unaffected family members


name: Crossing changes on visual evoked responses


name: Fair skin relative to unaffected family members


name: Fair hair relative to unaffected family members


name: Platelets show reduced secretion in response to ATP


name: Platelets lack dense bodies on electron microscopy


name: Light or hypopigmented skin compared to unaffected family members


name: Fair or lighter-colored scalp hair, eyebrows, and eyelashes than unaffected family members


name: Increased chiasmal decussation on visual evoked responses


name: Lighter skin color than unaffected family members


name: Abnormal aggregates of melanocytes within basal epidermal keratinocytes


name: Lighter hair color than unaffected family members


name: Abnormal core temperature oscillation patterns


name: Decreased mitochondrial complex III levels and activity in fibroblasts


name: Embryonal nuclear cataract with radiating, vacuolar, or dense opacities


name: Asymmetric anterior and posterior opacification


name: Lamellar cataract with sutural opacities


name: Punctate lens opacities limited to mid- and peripheral lamellae


name: Cortical and subcortical white matter lesions seen on brain MRI


name: Uterine prolapse after multiple deliveries


name: Bladder prolapse after multiple deliveries


name: Excessive weight gain after neonatal period


name: Epicanthal folds (in 2 brothers with homozygous mutation)


name: Amastia (absent breast tissue, nipple, and areola)


name: Absent nipples (athelia, unilateral or bilateral)


name: Increased frequency of transitional B cells


name: Prominent T-cell hyperplasia seen on tonsillar biopsy


name: Small B-cell follicles seen on tonsillar biopsy


name: Small, ill-defined germinal centers seen on tonsillar biopsy


name: Very few IgD+ mantle cells seen on tonsillar biopsy


name: Upper respiratory tract lymphoid hyperplasia


name: Encephalocele, occipital or suboccipital


name: T2-weighted hyperintensities and cavitations in the cerebellum


name: 'Onion bulb' formations seen on nerve biopsy


name: Midphalangeal hypoplasia of the 5th fingers (bilateral)


name: Enlarged ventricles with white matter involvement


name: Hypertrophy of interventricular septum, mild


name: Long QT interval on electrocardiography (ECG)


name: Platelets have defective ATP secretion in response to agonists


name: Platelet dense granule secretion defects


name: Defective megakaryocyte maturation and differentiation


name: Hypercellularity seen on bone marrow biopsy


name: Erythema (rapidly migrating figurate in annular, garland, or spiral pattern--erythema gyratum repens)


name: Hyperkeratotic plaques (well demarcated, symmetric with irregular borders)


name: Hyperpigmentation and scaling at frictional surfaces


name: Erythema (migrating transient figurate erythema--erythema gyratum repens)


name: Thickened scaly plaques (cheeks, periocular area, torso, legs, arms, and genitals)


name: Reduced or nonrecordable responses on electroretinography


name: Abnormally laminated retina on ocular coherence tomography (OCT)


name: Nonspecific abnormalities seen on brain imaging


name: Joint laxity of the small joints of the hand


name: Bilateral absence of patellar ossification centers


name: Large dark scales (thicker in areas of mechanical stress)


name: Eosinophilic granulocytes in stratum spinosum


name: Variable electron densities of horny material


name: Small vesicular inclusions in horny layer


name: Increased plasma sphingolipid intermediates and ceramide species


name: Disorganization of inner dynein arms seen on electron microscopy (EM)


name: Malformed or absent microtubule doublets


name: Absent central pair of singlet microtubules


name: Impaired T-cell proliferative response to multiple antigens


name: T-cell developmental and functional defects


name: Impaired ability to produce specific immunoglobulins


name: Normal levels of total serum immunoglobulins


name: Morphologic defects of most sperm flagella


name: Disorganization of inner dynein arms seen on scanning electron microscopy (SEM) of sperm


name: Absent central pair of singlet microtubules seen on scanning electron microscopy (SEM) of sperm


name: Renal biopsy shows tubulointerstitial nephritis


name: Mildly elevated succinylacetone in blood and urine seen on newborn screening


name: Multifocal epileptiform discharges seen on EEG


name: Nonspecific white matter abnormalities seen on brain imaging


name: Intellectual disability, variably severity


name: Short stature (-1.2 to -5 SD, 1 pt -8.4 SD)


name: Limb abnormalities, mainly upper limb, variable


name: Hearing loss, sensorineural (affects middle frequencies then all frequencies)


name: Glomerular sclerosis seen on renal biopsy


name: Arterial hypertension (due to renal disease)


name: Feeding difficulties in the newborn period


name: Hearing loss, progressive, moderate to profound


name: Defects in T-cell activation and proliferation


name: Deafness, prelingual, bilateral (severe to profound)


name: Postaxial polydactyly, unilateral or bilateral


name: No mitochondria in sperm seen on electron microscopy


name: Fusion of the cochlea and vestibule into a common cavity


name: Increased serum levels of 3-hydroxyanthranilic acid (3HAA)


name: Decreased serum levels of nicotinaminde adenine dinucleotide (NAD) and NAD(H)


name: Increased serum levels of 3-hydroxykynurenine (3HK)


name: Decreased serum levels of nicotinamide adenine dinucleotide (NAD) and NAD(H)


name: Hearing loss, bilateral, mild to moderate


name: Abnormal T2-weighted signals in the basal ganglia and brainstem


name: Hyperechogenic lungs seen on prenatal ultrasound


name: Extensive nonspecific fibrosis seen on renal biopsy


name: Estimated glomerular filtration rate (eGFR) in low-normal range


name: Fine scaling (predominantly on arms and knees)


name: Increased number of dilated eccrine sweat glands


name: Acantholytic appearance of epithelial cells of eccrine sweat glands


name: Delayed psychomotor development, mild, in infancy


name: Decreased head circumference, postnatal, progressive


name: Hyperintense white matter abnormalities (recessive)


name: Decreased mitochondrial mtDNA (recessive)


name: Increased numbers of abnormal mitochondria


name: Increased serum creatine kinase (recessive)


name: Fibroblasts show fragmented mitochondrial network


name: Euryblepharon (enlargement of the palpebral aperture)


name: Poor or absent speech Seizures, early-onset


name: Decreased mitochondrial complex V activity seen on muscle biopsy


name: Very low percentage of XY chromosome bivalents


name: Low percentage of metaphase spermatocytes


name: Intellectual disability, moderate to profound


name: Nonspecific abnormal periventricular white matter signals


name: Multifocal epileptiform discharges on EEG


name: Combined deficiency of mitochondrial respiratory complex activity, variable


name: Impaired auditory brainstem responses (ABRs)


name: Discrepancies between tonal and vocal audiometry


name: Fibroblasts show variable decreases in mitochondrial respiratory complex activities


name: Irregularly shaped capital femoral epiphyses


name: 'Swedish key' appearance of proximal femur, mild


name: Oocyte maturation arrest in germinal vesicle stage


name: Abnormal PB1 oocytes with large polar body


name: Early embryonic arrest of fertilized PB1 oocytes


name: Periventricular and subcortical T2-weighted white matter abnormalities seen on brain imaging


name: Unilateral fusion of occipito-mastoid suture


name: Cutaneous syndactyly, bilateral 2/3/4/5 Talipes equinovarus, bilateral


name: Lichenified hyperkeratotic plaques, symmetric (face, arms, axillae, legs, hands, feet)


name: Accentuated creases over knees and elbows


name: Peridigital constrictions on dorsa of fingers


name: Centralized nuclei seen on muscle biopsy


name: Sural nerve biopsy shows decreased myelination


name: Increased plasma levels of certain ceramides


name: Increased plasma levels of complex sphingolipids


name: Impaired antibody response to vaccination


name: Decreased number of switched memory B cells


name: Decreased or unobtainable amplitudes of sensory potentials


name: Decreased density of myelinated fibers seen on sural nerve biopsy


name: Disorganized background activity seen on EEG


name: Abnormal fluid signals suggestive of inflammation in the cochlea seen on imaging


name: Peripheral blood cells secrete abnormally high levels of IL-1B in response to stimulation with LPS


name: Increased serum markers of systemic inflammation


name: Renal biopsy shows minimal change disease


name: Patient cells show hypersensitivity to DNA cross-linking agents


name: Delayed myelination seen on brain imaging


name: Brain imaging shows simplified gyral pattern


name: Intellectual disability (IQ range 50-89)


name: Hyperpigmentation during febrile illness


name: HYPERLIPOPROTEINEMIA, TYPE III, AND ATHEROSCLEROSIS ASSOCIATED WITH APOE7


name: CROMER BLOOD GROUP SYSTEM, Dr(a-) PHENOTYPE


name: PITUITARY ADENOMA 3, ACTH-SECRETING, SOMATIC


name: Reduced amount of melanin pigment in melanocytes


name: Lack of platelet ATP secretion in response to agonists


name: Testicular tissue able to convert dehydroepiandrosterone and androstenedione to testosterone


name: Numerous large B cells in interfollicular area


name: DONSON, SER28ARG, c.786-33A-G (dbSNP rs192585552), AND LYS489THR (dbSNP rs146664036) HAPLOTYPE


name: Eventration of abdominal wall after surgery


name: Enlargement of the proximal metaphyses of the humerus


name: Dysmorphic facial features, mild, highly variable


name: Decreased diversional activity engagement


name: Risk for acute substance withdrawal syndrome


name: Expresses desire to enhance ability to read, write, speak and interpret numbers for everyday health needs


name: Expresses desire to enhance awareness of civic and/or government processes that impact public health


name: Expresses desire to enhance health communication with healthcare providers


name: Expresses desire to enhance knowledge of current determinants of health on social and physical environments


name: Expresses desire to enhance personal healthcare decision-making


name: Expresses desire to enhance social support for health


name: Expresses desire to enhance understanding of customs and beliefs to make healthcare decisions


name: Expresses desire to enhance understanding of health information to make healthcare choices


name: Expresses desire to obtain sufficient information to navigate the healthcare system


name: Insufficient knowledge of modifiable factors


name: Negative perception of health care provider


name: Negative perception of recommended health care strategy


name: Difficulty managing complex treatment regimen


name: Difficulty navigating complex healthcare systems


name: Breast milk expressed is less than prescribed volume for infant


name: Avoids participation in regular mealtimes


name: Frequently eating from fast food restaurants


name: Changes to self-esteem upon entering puberty


name: Media influence on eating behaviors of high caloric unhealthy foods


name: Media influence on knowledge of high caloric unhealthy foods


name: Negative parental influences on eating behaviors


name: Consumption of large volumes of food in a short period of time


name: Excessive parental control over child's eating experience


name: Excessive parental control over family mealtime


name: Unstructured eating of snacks between meals


name: Inability to divide eating responsibility between parent and child


name: Inability to divide feeding responsibility between parent and child


name: Inability to support healthy eating patterns


name: Lack of confidence in child to develop healthy eating habits


name: Lack of confidence in child to grow appropriately


name: Lack of knowledge of appropriate methods of feeding infant for each stage of development


name: Lack of knowledge of infant's developmental stages


name: Lack of knowledge of parent's responsibility in infant feeding


name: History of unsafe eating and feeding experiences


name: Blood type incompatibility between mother and infant


name: Excessive endogenous or exogenous glucocorticoids > 25 g/dl


name: Lumpy or hard stools in >= 25% defecations


name: Manual maneuvers to facilitate >= 25% of defecations (digital manipulation, pelvic floor support)


name: Sensation of anorectal obstruction/blockage for >= 25% of defecations


name: Sensation of incomplete evacuation for >= 25% of defecations


name: Large diameter stools that may obstruct the toilet


name: Presence of large fecal mass in the rectum


name: >= 1 episode of fecal incontinence per week


name: Dissonant rhythms of the energy field patterns


name: Expression of the need to regain the experience of the whole


name: Magnetic pull to an area of the energy field


name: Pulsating to pounding frequency of the energy field patterns


name: Temperature differentials of heat in the energy flow


name: Unsynchronized rhythms sensed in the energy flow


name: Interventions that disrupt the energetic pattern or flow


name: History of previous activity intolerance


name: Rapid absorption and distribution of anti-arrhythmia agent


name: Rapid absorption and distribution of diuretic agent


name: Rapid absorption and distribution of vasodilator agents


name: Alteration in at least one cognitive function other than memory


name: Inability to perform at least one daily activity


name: Insidious and irreversible onset in cognitive impairment


name: Progressive impairment in cognitive functioning


name: Consistently forgets to perform a behavior at the scheduled time


name: Persistent inability to learn a new skill


name: Persistent inability to learn new information


name: Persistent inability to perform a previously learned skill


name: Persistent inability to recall familiar names, words, or objects


name: Persistent inability to retain a new skill


name: Persistent inability to retain new information


name: Preserved capacity to perform daily activities independently


name: Apprehensive about future ability to provide care


name: Apprehensive about future health of care receiver


name: Not developmentally ready for caregiver role


name: Insufficient knowledge about substance misuse


name: Change in participation for problem-solving


name: Available work below educational preparation


name: Insufficient knowledge about the process to access resources in the host country


name: Insufficient social support in host country


name: Multiple non-related persons within household


name: Parent-child conflicts related to enculturation in the host country


name: Hazardous work conditions with inadequate training


name: Developed dependence to alcohol or other addictive substance


name: Heavy use of an addictive substance over time


name: Sudden cessation of an addictive substance


name: Iatrogenic substance exposure for pain control following a critical illness or surgery


name: Insufficient caregiver knowledge of behavioral cues


name: Insufficient environmental sensory stimulation


name: Difficulty reaching end-of-life decisions


name: Excessive number of personnel present during the surgical procedure


name: Sub-optimal American Society of Anaesthesiologists (ASA) physical health status score


name: Insufficient caregiver knowledge of safety precautions


name: Prolonged period of time catheter is in place


name: New York Heart Association (NYHA) Functional Classification >= 1


name: Infant less than 4 months, placed in sitting devices for routine sleep


name: Infant not breastfed exclusively or fed with expressed breast milk


name: First degree relative with history of venous thromboembolism


name: History of previous venous thromboembolism


name: Surgery and total anesthesia time > 90 minutes


name: Use of estrogen-containing contraceptives


name: Lack of family knowledge about impact of practice on physical health


name: Lack of family knowledge about impact of practice on psychosocial health


name: Lack of family knowledge about impact of practice on reproductive health


name: Belonging to ethnic group in which practice is accepted


name: Belonging to family in which any female member has been subjected to practice


name: Family leaders belong to ethnic group in which practice is accepted


name: Favorable attitude of family towards practice


name: Planning to visit family's country of origin


name: Residing in country where practice is accepted


name: Unprotected exposure to radioactive material


name: Improper use of personal protective equipment


name: Unsafe acts of unhealthy negative habits


name: Night shift work rotating to day shift work


name: Exposure to high environmental temperature


name: Media influence on feeding infant high caloric unhealthy foods


name: Increased environmental exposure to pathogens


name: Persistent inability to recall factual information or events


name: Risk for complicated immigration transition


name: Temperature differentials of cold in the energy flow


name: Angiotensin-converting enzyme inhibitor (disposition)


name: Hepatitis b virus (hbv) status not assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy, reason not otherwise specified


name: Niacinamide 1.6 g in 80 mL / Adenosine 0.03 g in 80 mL TOPICAL CREAM [LEBODY BU W RENEWAL UP]


name: TITANIUM DIOXIDE 2.099 g in 50 mL / ZINC OXIDE 3.5 g in 50 mL / OCTINOXATE 3.75 g in 50 mL TOPICAL CREAM [MISSHA M Perfect Cover BB Cream SPF42 (No. 25)]


name: Adenosine 0.004 g in 10 mL / Tranexamic acid 0.001 g in 10 mL TOPICAL LIQUID [SKINMD LABORATORIES ReviTox blue]


name: Dimethicone 1.61 g in 50 mL TOPICAL GEL [SKINMD LABORATORIES REVIGE L]


name: Glycerin 15.0 g in 150 mL TOPICAL GEL [LEBODY FACE RENEWAL]


name: Tranexamic acid 0.02 g in 10 mL / Adenosine 0.004 g in 10 mL TOPICAL CREAM [SKINMD LABORATORIES PURE WHITENOL INTENSIVE]


name: Tranexamic acid 0.05 g in 50 mL TOPICAL CREAM [SKINMD LABORATORIES PURE WHITENOL SERUM]


name: Similac Go & Grow Powder for Suspension (Vanilla)


name: Octinoxate 7.5 g in 100 g / Octisalate 5 g in 100 g / Oxybenzone 3 g in 100 g TOPICAL CREAM [Reclaim Revolutionary Anti-Aging Day SPF15]


name: TITANIUM DIOXIDE 65 mg in 1 mL / ZINC OXIDE 66.5 mg in 1 mL TOPICAL CREAM [Likewise Facial Moisturizer - Sun Protectant SPF 50 Oily Skin]


name: Titanium Dioxide 4 mg in 100 mL TOPICAL CREAM [Principal Secret Reclaim Oil Control hydrator SPF-8]


name: Aluminum Chlorohydrate 18% Topical application Solution [Ban Purely Gentle Invisible Roll-On Deodorant]


name: ZINC OXIDE 60 mg in 1 mL / TITANIUM DIOXIDE 23 mg in 1 mL TOPICAL CREAM [Isa SunGuard SPF 30]


name: AVOBENZONE 20 mg in 1 mL / OCTINOXATE 60 mg in 1 mL / OCTOCRYLENE 27 mg in 1 mL / OXYBENZONE 20 mg in 1 mL TOPICAL CREAM [ReVive Fermitif Neck Renewal SPF 15]


name: Avobenzone 2 mg in 100 mL / Homosalate 10 mg in 100 mL / Octisalate 5 mg in 100 mL / Octocrylene 1.3 mg in 100 mL / Oxybenzone 4 mg in 100 mL TOPICAL CREAM [Jane Seymour Natural Advantage AM SPF 15 All Day Moisture with AHAs]


name: HOMOSALATE 9 g in 100 g / AVOBENZONE 2.7 g in 100 g / OCTOCRYLENE 9 g in 100 g / OCTISALATE 4.5 g in 100 g TOPICAL STICK [BANANA BOAT]


name: OCTINOXATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL CREAM [Oil-Free Daily Hydration SPF 15]


name: OCTINOXATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL CREAM [Restorative Day Moisture SPF 15]


name: OCTINOXATE 7.5 g in 100 g / OCTISALATE 2.5 g in 100 g / ZINC OXIDE 7.5 g in 100 g TOPICAL LOTION


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL / ZINC OXIDE 111.6 mg in 1 mL TOPICAL CREAM [Likewise Facial Moisturizer - Sun Protectant SPF 50 Normal to Dry Skin]


name: OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 6 g in 100 g / AVOBENZONE 3 g in 100 g / HOMOSALATE 9 g in 100 g TOPICAL SPRAY [Banana Boat]


name: insulin aspart, human / insulin degludec


name: Capsicum extract / levomenthol / synthetic camphor


name: diclofenac sodium/methyl salicylate/menthol 1 %-30 %-10 % TOPICAL COMBINATION PACKAGE, CREAM AND GEL


name: tetrofosmin 1.38 mg intravenous powder for injection


name: Clever Choice Comfort EZ 29G 1/2 inch Pen Needle


name: Clever Choice Comfort EZ 32G 1/4 inch Pen Needle


name: Clever Choice Comfort EZ 32G 3/16 inch Mini Pen Needle


name: Clever Choice Comfort EZ 33G 5/32 inch Micro Pen Needle


name: Clever Choice Comfort EZ 33G 5/32 inch Pen Needle


name: Clever Choice Talking Wrist Type Premium Blood Pressure Monitor


name: Clever Choice Upper Arm Elite Blood Pressure Monitor


name: Clever Choice Upper Arm Talking Blood Pressure Monitor


name: Clever Choice Wrist Electronic Blood Pressure Monitor


name: FreeStyle Libre 10-d Reader Glucose Monitoring System


name: FreeStyle Libre 10-d Sensor Glucose Monitoring System


name: Levomefolate Calcium 7.5mg, Algal Oil 90.314mg Oral capsule


name: Member's Mark 0.3mL 30G 5/16 inch Short Needle Insulin Syringe


name: Member's Mark 0.3mL 31G 5/16 inch Short Needle Insulin Syringe


name: Member's Mark 0.5mL 30G 5/16 inch Short Needle Insulin Syringe


name: Member's Mark 0.5mL 31G 5/16 inch Short Needle Insulin Syringe


name: Member's Mark 1mL 30G 5/16 inch Short Needle Insulin Syringe


name: Member's Mark 1mL 31G 5/16 inch Short Needle Insulin Syringe


name: Member's Mark Easy Touch Blood Glucose Meter Kit


name: Member's Mark Easy Touch Blood Glucose Test Strip


name: Member's Mark Easy Touch Twist Lancet 30G


name: Member's Mark Easy Touch Twist Lancet 32G (Teal)


name: UltiCare 1mL 27G 1/2 inch Tuberculin Safety Syringe


name: UltiCare 1mL 27G 5/8 inch Tuberculin Safety Syringe


name: UltiCare 1mL 28G 1/2 inch Tuberculin Safety Syringe


name: UltiCare 3/10ML 31G 1/4 inch 1/2 Unit Markings Insulin Syringe


name: UltiCare 3ML 21G 1-1/2 inch Luer Lock Safety Syringe


name: UltiCare 3mL 22G 1 inch Luer Lock Safety Syringe


name: UltiCare 3mL 22G 1-1/2 inch Luer Lock Safety Syringe


name: UltiCare 3mL 23G 1 inch Luer Lock Safety Syringe


name: UltiCare 3mL 25G 1 inch Luer Lock Safety Syringe


name: UltiCare 3mL 25G 5/8 inch Luer Lock Safety Syringe


name: OCTINOXATE 7.5 g in 100 mL / OCTISALATE 2.5 g in 100 mL / OCTOCRYLENE 2.5 g in 100 mL / ZINC OXIDE 7 g in 100 mL TOPICAL LOTION [Olay Complete UV365 Daily Moisturizer with Sunscreen Broad Spectrum SPF 30 Sensitive]


name: DRESSING,CUTIMED SILTEC SORBACT 3IN X 3IN #7992900


name: CATHERIZATION SET,INTERMITTENT 16FR BARD #4A5146


name: CATHETER,FOLEY SILICONE 2-WAY 22FR 30ML RUSCH #170630220


name: CATHETER,INTERMITTENT 18FR LOFRIC PRIMO #4101840


name: DRESSING,POLYMEM AG 1.8IN X 1.8IN,FERRIS #1022


name: DRESSING,POLYMEM AG 6.5IN X 7.5IN,FERRIS #1077


name: DRESSING,TEGADERM IV ADVANCED 2.5IN X 2.75IN


name: SET,INFUSION,FLOW REGULATOR,84IN W/DRIP CHAMBER #KS-122-2


name: TRACHEAL SUCTION SET 14FR HALYARD #22109


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTINOXATE 7.5 g in 100 mL / OCTISALATE 2.75 in 100 mL / OXYBENZONE 5 in 100 mL TOPICAL LOTION [SPF 30 face Moisturizer]


name: Titanium Dioxide 0.7 g in 100 mL / Zinc Oxide 4.75 g in 100 mL TOPICAL LOTION [UNBLEMISH Control Broad Spectrum SPF 20]


name: IMIPENEM 1 kg in 1 kg NOT APPLICABLE POWDER [Imipenem]


name: PANTHENOL 0.162 mg in 27 mL / ALLANTOIN 0.081 mg in 27 mL TOPICAL PATCH [MARINE PURIFYING]


name: nutritional therapy for phenylketonuria (PKU) no.70 20 gram-100 kcal/174 mL ORAL LIQUID IN PACKET (ML)


name: parenteral electrolytes combination no.25


name: MITOMYCIN 4.95 g in 5 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: nutritional therapy phenylketonuria (PKU) no.70


name: Mary Kay TimeWise Repair Volu-Firm The Go Set KIT


name: SENSI-CARE NO STING BARRIER SPRAY C#413502


name: HOMOSALATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 26 mg in 1 mL TOPICAL LOTION [NIA 24 SPF 30]


name: Titanium Dioxide 2.61 g in 18 g / Octocrylene 1.80 g in 18 g / Homosalate 1.80 g in 18 g / Octisalate 0.90 g in 18 g / Avobenzone 0.54 g in 18 g TOPICAL STICK [WKND UNDERWATER SUN TAN]


name: Titanium Dioxide 4.36 g in 18 g / Octocrylene 1.80 g in 18 g / Homosalate 1.80 g in 18 g / Octisalate 0.90 g in 18 g / Avobenzone 0.54 g in 18 g TOPICAL STICK [WKND UNDERWATER SUN WHITE]


name: ZINC OXIDE 163.2 mg in 1 mL TOPICAL CREAM [Everyday Facial Moisturizer And Sunscreen SPF 20]


name: Zinc Oxide 5.0 g in 50 mL / Titanium Dioxide 4.0 g in 50 mL TOPICAL CREAM [ECO BARRIER NON CHEMICAL SUN]


name: Niacinamide 0.50 g in 25 g / Adenosine 0.01 g in 25 g TOPICAL PATCH [RED GINSENG BRIGHTENING MASK PACK]


name: Niacinamide 0.80 g in 40 g / Adenosine 0.016 g in 40 g TOPICAL PATCH [RED GINSENG VITALIZING HYDROG EL MASK]


name: RANITIDINE HYDROCHLORIDE .99 kg in 1 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: Excedrin PM Triple Action Caplets and Excedrin Tension Headache KIT


name: GLYCERIN 0.5 mg in 1 mL TOPICAL GEL [Glyzigen Single Dose Intimate Gel]


name: PIMOBENDAN 49.5 g in 50 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: ZINC OXIDE 24.5 g in 100 g TOPICAL POWDER [Invincible Setting Powder SPF 45 Deep]


name: ceftriaxone and beta-lactamase inhibitor


name: bictegravir / emtricitabine / tenofovir alafenamide


name: cobicistat / darunavir / emtricitabine / tenofovir alafenamide


name: formoterol, glycopyrronium bromide and beclometasone


name: ramipril, amlodipine and hydrochlorothiazide


name: rosuvastatin, amlodipine and perindopril


name: rosuvastatin, perindopril and indapamide


name: vilanterol, umeclidinium bromide and fluticasone furoate


name: Human immunodeficiency virus fusion inhibitor (disposition)


name: cefoperazone and beta-lactamase inhibitor


name: ceftazidime and beta-lactamase inhibitor


name: OCTISALATE 1.75 g in 35 mL / ZINC OXIDE 1.68 g in 35 mL / TITANIUM DIOXIDE 0.8715 g in 35 mL / OCTINOXATE 2.625 g in 35 mL TOPICAL CREAM [Laser Sunscreen 100]


name: AVOBENZONE 10 mg in 1 g / OCTINOXATE 10 mg in 1 g / OCTOCRYLENE 5 mg in 1 g TOPICAL CREAM [Pro-Collagen Marine Broad Spectrum SPF 30]


name: AVOBENZONE 8 mg in 1 g / OCTINOXATE 35 mg in 1 g / OXYBENZONE 5 mg in 1 g TOPICAL CREAM [Laura Mercier Flawless Skin Repair Day Creme Broad Spectrum SPF 15 Sunscreen]


name: DIMETHICONE 2 g in 100 g / OCTINOXATE 6.6 g in 100 g / OCTISALATE 4.4 g in 100 g TOPICAL STICK [Blistex Medicated Berry Balm]


name: DIMETHICONE 2 g in 100 g / OCTINOXATE 6.6 g in 100 g / OCTISALATE 4.4 g in 100 g TOPICAL STICK [Blistex Medicated Lip Balm]


name: DIMETHICONE 2 g in 100 g / OCTINOXATE 6.6 g in 100 g / OCTISALATE 4.4 g in 100 g TOPICAL STICK [Blistex Medicated Mint Balm]


name: orchard grass pollen extract / Timothy grass pollen extract


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 27 mg in 1 mL TOPICAL LOTION [CeraVe Developed with Dermotologists Ultra Light Moisturizing Broad Spectrum SPF 30]


name: TELMISARTAN 247.5 g in 250 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: X-ray taken using computed radiography technology/cassette-based imaging


name: Drug or biological acquired with 340b drug pricing program discount (JG)


name: Service furnished under a reciprocal billing arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area


name: Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area


name: Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes (TB)


name: Medicare diabetes prevention program (mdpp) virtual make-up session


name: Continuous/broad services: for reporting services by clinicians, who provide the principal care for a patient, with no planned endpoint of the relationship; services in this category represent comprehensive care, dealing with the entire scope of patient problems, either directly or in a care coordination role; reporting clinician service examples include, but are not limited to: primary care, and clinicians providing comprehensive care to patients in addition to specialty care


name: Continuous/focused services: for reporting services by clinicians whose expertise is needed for the ongoing management of a chronic disease or a condition that needs to be managed and followed with no planned endpoint to the relationship; reporting clinician service examples include but are not limited to: a rheumatologist taking care of the patient's rheumatoid arthritis longitudinally but not providing general primary care services


name: Episodic/broad services: for reporting services by clinicians who have broad responsibility for the comprehensive needs of the patient that is limited to a defined period and circumstance such as a hospitalization; reporting clinician service examples include but are not limited to the hospitalist's services rendered providing comprehensive and general care to a patient while admitted to the hospital


name: Episodic/focused services: for reporting services by clinicians who provide focused care on particular types of treatment limited to a defined period and circumstance; the patient has a problem, acute or chronic, that will be treated with surgery, radiation, or some other type of generally time-limited intervention; reporting clinician service examples include but are not limited to, the orthopedic surgeon performing a knee replacement and seeing the patient through the postoperative period


name: Diagnostic services requested by another clinician: for reporting services by a clinician who furnishes care to the patient only as requested by another clinician or subsequent and related services requested by another clinician; this modifier is reported for patient relationships that may not be adequately captured by the above alternative categories; reporting clinician service examples include but are not limited to, the radiologist's interpretation of an imaging study requested by another clinician


name: Adjunctive blue light cystoscopy with fluorescent imaging agent (list separately in addition to code for primary procedure)


name: Wheelchair accessory, lateral thigh or knee support, any type including fixed mounting hardware, each


name: Wheelchair accessory, foot box, any type, includes attachment and mounting hardware, each foot


name: Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preventive service)


name: Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; each additional 30 minutes (list separately in addition to code g0513 for additional 30 minutes of preventive service)


name: Insertion of non-biodegradable drug delivery implants, 4 or more (services for subdermal rod implant)


name: Removal of non-biodegradable drug delivery implants, 4 or more (services for subdermal implants)


name: Removal with reinsertion, non-biodegradable drug delivery implants, 4 or more (services for subdermal implants)


name: Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes


name: Trans-abdominal or trans-vaginal ultrasound not performed, reason not given


name: Documentation of medical reason(s) for not prescribing an fda-approved anticoagulant (e.g., present or planned atrial appendage occlusion or ligation or patient being currently enrolled in a clinical trial related to af/atrial flutter treatment)


name: Documentation of patient reason(s) for not prescribing an oral anticoagulant that is fda approved for the prevention of thromboembolism (e.g., patient preference for not receiving anticoagulation)


name: Documented reason for not assessing hepatitis b virus (hbv) status (e.g., patient not initiating anti-tnf therapy, patient declined) prior to initiating anti-tnf therapy


name: At least two orders for high-risk medications from the same drug class


name: At least two orders for high-risk medications from the same drug class not ordered


name: Patient in hospice at any time during the measurement period


name: Patient had at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays


name: Patient did not have at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays


name: Documentation that the patient declined change in medication or alternative therapies were unavailable, has documented contraindications, or has not been treated with a systemic medication for at least six consecutive months (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi


name: Ras (kras and nras) gene mutation testing performed before initiation of anti-egfr moab


name: Ras (kras and nras) gene mutation testing not performed before initiation of anti-egfr moab


name: Androgen deprivation therapy prescribed/administered in combination with external beam radiotherapy to the prostate


name: Documentation of medical reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate (e.g., salvage therapy)